FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2Fei Xu, Xiaohua Wu|Molecular Cancer|2021Cited by 139
m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathwaysXiaotian Han, Xiaohua Wu|Oncogene|2025Cited by 13
Supplementary Figure from Pamiparib Monotherapy for Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Beihua Kong, Jianqing Zhu et al.|Unknown|2023Cited by 0
Supplementary Data from Pamiparib Monotherapy for Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Beihua Kong, Jianqing Zhu et al.|Unknown|2023Cited by 0
Supplementary Figure from Pamiparib Monotherapy for Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Beihua Kong, Jianqing Zhu et al.|Unknown|2023Cited by 0